LeukoDx is a development stage company advancing its novel compact flow cytometry technology platform.  The platform development was initiated at Caltech with NASA funding.

This groundbreaking technology has a wide range of potential applications, from early sepsis detection and monitoring, to HIV/AIDS monitoring and beyond.

Our platform will deliver fast, actionable, sophisticated tests results at the point of care or in the field in 10 minutes or less.  This will help making better medical decisions when and where patient need them. It will also make cell based diagnostics test results accessible to a greater number of people than ever before.